Dr. Daniele Fanale, PhD, Executive Biologist at the Sicilian Regional Center for the Prevention, Diagnosis and Treatment of Rare and Heredo-Familial Tumors, the Section of Medical Oncology, University Hospital Policlinico P. Giaccone of Palermo (Italy). PhD in Molecular and Cellular Oncopathology at the University of Palermo (Italy) in 2010. In previous years, he has acquired experience and expertise in the field of microarray technologies, in particular, in gene and miRNA expression analysis and gene copy number variation analysis. Recently, he has been involved in projects involving translational oncology research aimed at identifying new potential biomarkers in cancer for diagnostic, prognostic, and predictive purposes. In this context, he has been concerned with the molecular genetics of sporadic, hereditary, and familial tumors. In the last year, he has also been involved in projects concerning immuno-oncology.
Dr. Daniele Fanale, PhD, Executive Biologist at the Sicilian Regional Center for the Prevention, Diagnosis and Treatment of Rare and Heredo-Familial Tumors, the Section of Medical Oncology, University Hospital Policlinico P. Giaccone of Palermo (Italy). PhD in Molecular and Cellular Oncopathology at the University of Palermo (Italy) in 2010. In previous years, he has acquired experience and expertise in the field of microarray technologies, in particular, in gene and miRNA expression analysis and gene copy number variation analysis. Recently, he has been involved in projects involving translational oncology research aimed at identifying new potential biomarkers in cancer for diagnostic, prognostic, and predictive purposes. In this context, he has been concerned with the molecular genetics of sporadic, hereditary, and familial tumors. In the last year, he has also been involved in projects concerning immuno-oncology.